Cargando…

Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment

The rise of antibiotic resistance and the growing number of biofilm-related infections make bacterial infections a serious threat for global human health. Nanomedicine has entered into this scenario by bringing new alternatives to design and develop effective antimicrobial nanoweapons to fight again...

Descripción completa

Detalles Bibliográficos
Autores principales: Colilla, Montserrat, Vallet-Regí, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696808/
https://www.ncbi.nlm.nih.gov/pubmed/33203098
http://dx.doi.org/10.3390/ijms21228605
_version_ 1783615488748683264
author Colilla, Montserrat
Vallet-Regí, María
author_facet Colilla, Montserrat
Vallet-Regí, María
author_sort Colilla, Montserrat
collection PubMed
description The rise of antibiotic resistance and the growing number of biofilm-related infections make bacterial infections a serious threat for global human health. Nanomedicine has entered into this scenario by bringing new alternatives to design and develop effective antimicrobial nanoweapons to fight against bacterial infection. Among them, mesoporous silica nanoparticles (MSNs) exhibit unique characteristics that make them ideal nanocarriers to load, protect and transport antimicrobial cargoes to the target bacteria and/or biofilm, and release them in response to certain stimuli. The combination of infection-targeting and stimuli-responsive drug delivery capabilities aims to increase the specificity and efficacy of antimicrobial treatment and prevent undesirable side effects, becoming a ground-breaking alternative to conventional antibiotic treatments. This review focuses on the scientific advances developed to date in MSNs for infection-targeted stimuli-responsive antimicrobials delivery. The targeting strategies for specific recognition of bacteria are detailed. Moreover, the possibility of incorporating anti-biofilm agents with MSNs aimed at promoting biofilm penetrability is overviewed. Finally, a comprehensive description of the different scientific approaches for the design and development of smart MSNs able to release the antimicrobial payloads at the infection site in response to internal or external stimuli is provided.
format Online
Article
Text
id pubmed-7696808
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76968082020-11-29 Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment Colilla, Montserrat Vallet-Regí, María Int J Mol Sci Review The rise of antibiotic resistance and the growing number of biofilm-related infections make bacterial infections a serious threat for global human health. Nanomedicine has entered into this scenario by bringing new alternatives to design and develop effective antimicrobial nanoweapons to fight against bacterial infection. Among them, mesoporous silica nanoparticles (MSNs) exhibit unique characteristics that make them ideal nanocarriers to load, protect and transport antimicrobial cargoes to the target bacteria and/or biofilm, and release them in response to certain stimuli. The combination of infection-targeting and stimuli-responsive drug delivery capabilities aims to increase the specificity and efficacy of antimicrobial treatment and prevent undesirable side effects, becoming a ground-breaking alternative to conventional antibiotic treatments. This review focuses on the scientific advances developed to date in MSNs for infection-targeted stimuli-responsive antimicrobials delivery. The targeting strategies for specific recognition of bacteria are detailed. Moreover, the possibility of incorporating anti-biofilm agents with MSNs aimed at promoting biofilm penetrability is overviewed. Finally, a comprehensive description of the different scientific approaches for the design and development of smart MSNs able to release the antimicrobial payloads at the infection site in response to internal or external stimuli is provided. MDPI 2020-11-15 /pmc/articles/PMC7696808/ /pubmed/33203098 http://dx.doi.org/10.3390/ijms21228605 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Colilla, Montserrat
Vallet-Regí, María
Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment
title Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment
title_full Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment
title_fullStr Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment
title_full_unstemmed Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment
title_short Targeted Stimuli-Responsive Mesoporous Silica Nanoparticles for Bacterial Infection Treatment
title_sort targeted stimuli-responsive mesoporous silica nanoparticles for bacterial infection treatment
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7696808/
https://www.ncbi.nlm.nih.gov/pubmed/33203098
http://dx.doi.org/10.3390/ijms21228605
work_keys_str_mv AT colillamontserrat targetedstimuliresponsivemesoporoussilicananoparticlesforbacterialinfectiontreatment
AT valletregimaria targetedstimuliresponsivemesoporoussilicananoparticlesforbacterialinfectiontreatment